Clinical trials of biologics
The group has a fully staffed clinical trials unit that is world leading in studies of new targeted biological therapies for psoriasis including:
- TNF antagonists
- T cell activation blockers
- IL-12/IL-23 antagonists
The unit was established in 1994 and is one of Europe's leading dermatology clinical trials units.
We are always looking for volunteers with psoriasis, and volunteers with no active skin conditions to participate in clinical trials. For more information visit our Skin Research website.